苏州招聘

Principal Responsibilities


1. Functions as a trainee Study Director. Prior to promotion to the Scientist level, the Assistant Scientist will have performed satisfactorily for at least a-12 month period* in assisting in all aspects of the Study Director role (as defined in the Position Description for the Scientist) and will have been judged by the Scientific Director and Director of Toxicology to be competent to be a Study Director.


2. Functions as a junior study manager under the guidance of the Study Director. The Assistant Scientist is not permitted to be the authorizing signatory on any driving document, but can be involved in study performance as follows:


a) Participate in preparation of schedule of study activities within contributing departments.
b) Able to plan and coordinate upcoming studies.
c) Able to monitor and control studies and problem solve.
d) Able to implement and monitor appropriate techniques of test article administration.
e) Aware and conversant with all associated SOPs.
f) Fully aware of appropriate Good Laboratory Practices.
g) Prepare study schedules, protocols, protocol amendments and draft reports.
h) Limited exposure to client contact with supervision of Study Director
i) Satisfactory performance in Toxicology/Other Examinations required for progression to Scientist I.


3. Familiarization with appropriate regulations, guidelines and guidances.


4. The Assistant Scientist must ensure that a safe working environment is maintained by all project related staff through the observance of safety procedures, the use of protective clothing or equipment and by the distribution of relevant safety information.
5. This may be period may vary depending on experience and the applicants apptitude


Qualifications


Ph.D., D.V.M., M.Sc., or B.Sc. in Toxicology or related biological discipline or suitable other experience.


Alternatively, the candidate must be in the process of obtaining a Scientific degree.

苏州药明康德成立于2006年10月，是药明康德全资子公司，旨在在总公司不断成熟的技术能力及不断强大的经济实力的基础上，开拓一个完全不同于上海药明康德的全新领域,为国内外新药开发提供高端药物非临床研究评价服务。

苏州药明康德已建成面积达三万多平方米的药物安全评价研究中心。该研究中心目前向全球客户提供符合GLP标准的遗传毒性实验服务，并通过了国际实验动物评估认证管理委员会（AAALAC）的国际认证；中国食品药品监督局SFDA的GLP认证；欧洲OECD的GLP认证；是全球唯一一家通过全面资质认证的药物安全性评价中心。公司在2010年下半年开始提供符合GLP标准的一般毒理研究服务，并通过中国SFDA和欧洲OECD的GLP认证；2013年将提供全面的临床前安全评价研究服务。

同时，苏州药明康德拥有众多获得资格认证的毒理学家和病理学家们，能够为国内外客户提供包括大（包括猴、犬）小（包括啮齿类、家兔）动物的急性毒性、长期毒性、药代/毒代、生殖毒性、安全性药理、遗传毒性等药物安全性评价项目以及体内外药物筛选、药理药效研究等。

以新药研发及安全评价服务为主要业务，苏州药明康德将不断增强其研发实力，扩宽其服务领域，为将药明康德打造成全方位、一体化的药物研发服务平台而努力。

我们欢迎各地英才的加盟，与药明康德一起，发展和进步。药明康德将为员工提供良好的职业前景和众多的培训机会以及有竞争的薪资福利。